Hum. Reprod. Advance Access originally published online on May 5, 2006
Human Reproduction 2006 21(8):2022-2026; doi:10.1093/humrep/del127
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles
1 IVF-Unit, Landes- Frauen- und Kinderklinik, Linz, Austria and 2 Department of Laboratory Medicine, Landes- Frauen- und Kinderklinik, Linz, Austria
3 To whom correspondence should be addressed at: IVF-Unit, Landes- Frauen- und Kinderklinik, Krankenhausstraße 26-30, A-4020 Linz, Austria. E-mail: thomas.ebner{at}gespag.at
BACKGROUND: Serum anti-Müllerian hormone (AMH) levels provide a powerful means for predicting ovarian response, which is reflected not only by the size of the primordial follicle pool but also by the quality of the oocytes. Considering a mutual interdependence between AMH-expressing somatic cells and gametes, this prospective morphological study was set up to evaluate whether extreme AMH levels represent diminished oocyte quality and developmental incompetence. METHODS: A total of 141 consecutive ICSI patients were subdivided into three groups using the 25th and 75th percentiles of the serum AMH levels (cycle day 3). In these three groups, morphology of all oocytes and fertilization rate, embryo quality and blastocyst formation were evaluated, and FSH, LH and estradiol (E2) levels were also measured. RESULTS: Cycle cancellation rate was correlated with AMH levels (P < 0.05). AMH groups 1 (<1.66 ng/ml) and 3 (>4.52 ng/ml) showed oocytes of lower quality [dark central granulation, aggregation of smooth endoplasmic reticulum (sER)] compared with the median group 2 (1.66–4.52 ng/ml). Basal serum FSH did not allow for adequate prognosis in terms of gamete appearance. Fertilization and further cleavage up to blastocyst stage was not affected by AMH levels. CONCLUSIONS: AMH seems to be superior to FSH in predicting both oocyte number and quality.
Key words: AMH/central granulation/cycle cancellation/FSH/oocyte quality
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D.A. Dumesic, M.S. Patankar, D.K. Barnett, T.G. Lesnick, B.A. Hutcherson, and D.H. Abbott Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys Hum. Reprod., December 1, 2009; 24(12): 3188 - 3195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, A. C. Artenisio, G. Stabile, and A. Volpe Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum. Reprod. Update, September 30, 2009; (2009) dmp036v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. La Marca, F.J. Broekmans, A. Volpe, B.C. Fauser, N.S. Macklon, and on behalf of the ESHRE Special Interest Group for Anti-Mullerian hormone (AMH): what do we still need to know? Hum. Reprod., September 1, 2009; 24(9): 2264 - 2275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Catteau-Jonard, S. P. Jamin, A. Leclerc, J. Gonzales, D. Dewailly, and N. di Clemente Anti-Mullerian Hormone, Its Receptor, FSH Receptor, and Androgen Receptor Genes Are Overexpressed by Granulosa Cells from Stimulated Follicles in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4456 - 4461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Jayaprakasan, B.K. Campbell, J.F. Hopkisson, J.S. Clewes, I.R. Johnson, and N.J. Raine-Fenning Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone Hum. Reprod., November 1, 2008; 23(11): 2577 - 2583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Sowers, A. D. Eyvazzadeh, D. McConnell, M. Yosef, M. L. Jannausch, D. Zhang, S. Harlow, and J. F. Randolph Jr. Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3478 - 3483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gnoth, A.N. Schuring, K. Friol, J. Tigges, P. Mallmann, and E. Godehardt Relevance of anti-Mullerian hormone measurement in a routine IVF program Hum. Reprod., June 1, 2008; 23(6): 1359 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Nelson, R. W. Yates, and R. Fleming Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy Hum. Reprod., September 1, 2007; 22(9): 2414 - 2421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Al-Qahtani and N. P. Groome Anti-Mullerian Hormone: Cinderella Finds New Admirers. J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3760 - 3762. [Full Text] [PDF]
|
|